These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 479381)

  • 1. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Kopferschmitt J; Spach MO; Grudet O; Lavillaureix J
    J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefamandole in patients with renal impairment.
    Czerwinski AW; Pederson JA
    Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of cefalexin pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Pinget M; Dorner M; Lavillaureix J
    J Clin Pharmacol; 1975 Oct; 15(10):666-73. PubMed ID: 1184770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function.
    Brogard JM; Comte F; Spach MO; Lavillaureix J
    Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefamandole kinetics in uremic patients undergoing hemodialysis.
    Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
    Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
    Hess JR; Berman SJ; Boughton WH; Sugihara JG; Musgrave JE; Wong EG; Siemsen AM
    Antimicrob Agents Chemother; 1980 Feb; 17(2):251-3. PubMed ID: 7387145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
    Ahern MJ; Finkelstein FO; Andriole VT
    Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceforanide kinetics in renal insufficiency.
    Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT
    J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT; Conte JE
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephacetrile--application of pharmacokinetic data to dosage determination.
    Brogard JM; Dorner M; Brandt C; Lavillaureix J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):168-76. PubMed ID: 950258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.
    Appel GB; Neu HC; Parry MF; Goldberger MJ; Jacob GB
    Antimicrob Agents Chemother; 1976 Oct; 10(4):623-5. PubMed ID: 984799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.